Logo
C

Colossal Biosciences

179 employees

The science of genetics. The business of discovery. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

Investor insights

Funding rounds participated in

$200M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2021

Funding rounds raised

Total raised

$200M

from 3 investors over 1 rounds

C

Colossal Biosciences raised $200M on February 15, 2025

Investors: TWG Global, Thomas Tull and + 1 Other investor

FAQ